Cargando…
Dysport and Botox at a Ratio of 2.5:1 Units in Cervical Dystonia: A Double-Blind, Randomized Study
We aimed to compare Dysport (abobotulinumtoxinA, Ipsen Biopharm, Slough, UK) and Botox (onabotulinumtoxinA, Allergan, Irvine, CA, USA) at a 2.5:1 ratio in the treatment of cervical dystonia (CD). A Dysport/Botox ratio of lower than 3:1 was suggested as a more appropriate conversion ratio, considerin...
Autores principales: | Yun, Ji Young, Kim, Jae Woo, Kim, Hee-Tae, Chung, Sun Ju, Kim, Jong-Min, Cho, Jin Whan, Lee, Jee-Young, Lee, Ha Neul, You, Sooyeoun, Oh, Eungseok, Jeong, Heejeong, Kim, Young Eun, Kim, Han-Joon, Lee, Won Yong, Jeon, Beom S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BlackWell Publishing Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4359015/ https://www.ncbi.nlm.nih.gov/pubmed/25476727 http://dx.doi.org/10.1002/mds.26085 |
Ejemplares similares
-
Conversion Ratio between Botox(®), Dysport(®), and Xeomin(®) in Clinical Practice
por: Scaglione, Francesco
Publicado: (2016) -
Content of Botulinum Neurotoxin in Botox®/Vistabel®, Dysport®/Azzalure®, and Xeomin®/Bocouture®
por: Frevert, Jürgen
Publicado: (2012) -
AbobotulinumtoxinA (Dysport(®)), OnabotulinumtoxinA (Botox(®)), and IncobotulinumtoxinA (Xeomin(®)) Neurotoxin Content and Potential Implications for Duration of Response in Patients
por: Field, Malgorzata, et al.
Publicado: (2018) -
Efficacy of Onabotulinum Toxin A (Botox) versus Abobotulinum Toxin A (Dysport) Using a Conversion Factor (1 : 2.5) in Treatment of Primary Palmar Hyperhidrosis
por: El Kahky, Hanan Mohamed, et al.
Publicado: (2013) -
Double-Blind, Randomized, Comparative Study of Meditoxin® Versus Botox® in the Treatment of Essential Blepharospasm
por: Yoon, Jin Sook, et al.
Publicado: (2009)